Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 358 participants.
Also called NCT07296744
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 358 participants
- Sponsor
- Supira Medical
- Registry
-
NCT07296744
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07296744. Randomized; no masking; primary purpose treatment. Start 2026-05-11 (actual); primary completion 2027-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
- Acronym
- SUPPORT II
- Condition
- Coronary Artery Disease
- Condition
- High Risk Percutaneous Coronary Intervention
- Condition
- Interventional Cardiology
- Condition
- Mechanical Circulatory Support
- Intervention (Device)
- The Supira System
- Intervention (Device)
- Impella
- Lead sponsor
- Supira Medical
Record details
- Record id
cardio:ct-nct07296744- Content hash
4334b738c3047f02fcd4b1dd2d46c06f564ef6bffa42445c8b8c98e0ffb11be0